Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20000787HPVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS20010614HPVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS20006685HPVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS20062059HPVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS20062240HPVENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS44033258HTLV-1ENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS44016804HTLV-1ENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS44015123HTLV-1ENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TVIS44012059HTLV-1ENSG00000146648.21protein_codingEGFRYesNo1956E7BSV0
P00533
Q504U8
TCGA Plot Options
Drug Information
GeneEGFR
DrugBank IDDB05524
Drug NamePelitinib
Target IDBE0000767
UniProt IDP00533
Regulation Type
PubMed IDs16364494
CitationsYoshimura N, Kudoh S, Kimura T, Mitsuoka S, Matsuura K, Hirata K, Matsui K, Negoro S, Nakagawa K, Fukuoka M: EKB-569, a new irreversible epidermal growth factor receptor tyrosine kinase inhibitor, with clinical activity in patients with non-small cell lung cancer with acquired resistance to gefitinib. Lung Cancer. 2006 Mar;51(3):363-8. Epub 2005 Dec 20.
GroupsInvestigational
Direct Classification
SMILESCCOC1=CC2=C(C=C1NC(=O)C=CCN(C)C)C(NC1=CC(Cl)=C(F)C=C1)=C(C=N2)C#N
Pathways
PharmGKB
ChEMBLCHEMBL607707